Shilpa Medicare Ltd

Shilpa Medicare's Subsidiary Enters Latin America with Biosimilar Licensing Deal 🌎💊

• Shilpa Biologicals Pvt Ltd (SBPL) signed a licensing agreement with Steincares, Costa Rica.

• Steincares gains exclusive rights to register, commercialize, and distribute a biosimilar across Latin America.

• Shilpa Biologicals will complete product development and provide long-term commercial manufacturing from its facility in Dharwad, India.

• This marks Shilpa Biologicals' first entry into the Latin American market and the first product from this partnership.

• The partnership aims to expand patient access to cost-effective biosimilar treatments in Latin America.

• Steincares has over 45 years of experience and operates in 30 countries across Latin America and the Caribbean.

• Shilpa Biologicals focuses on biosimilars in immunology, oncology, and ophthalmics, with a pipeline at various development stages.